The overarching goal of the Cancer Center is to shepherd new approaches to cancer prevention, detection, and treatment into clinical and population settings, where they can be tested and evaluated. Multidisciplinary programs -- which include lab scientists, clinical investigators, providers of patient care, epidemiologists, and socio-behavioral scientists -- facilitate this process by focusing research on relevant issues to patients and persons at risk of cancer. Collaboration across disciplines ensures that insights gained in the lab can move quickly and effectively to cancer patients’ bedsides and to cancer prevention and control programs.
UCSF’s investigators aim to test the scientific insights gained in the lab against the real-world standards of patient care and disease prognosis. Clinical trials of new pharmaceutical agents and gene therapies, as well as improvements on existing drug regimens and radiotherapeutic treatments, pose hypotheses and answer questions for both physicians and patients. UCSF researchers participate in national cooperative groups, through which widely available clinical trials can provide conclusive data on promising therapies. They also design their own protocols for studies that follow closely on lab research and provide “proof of concept” for cutting-edge approaches. Just as the Center’s philosophy is based on collaboration among basic scientists and clinical health care providers, ultimate progress in the struggle against cancer will come from collaboration among scientists and cancer patients themselves.
The following is a list of myeloma clinical trials at this center.
View all active clinical trials around the US.
The following is a listing of clinical trials for patients with multiple myeloma who have been newly diagnosed or have not yet received treatment.
The following is a listing of clinical trials for patients with multiple myeloma who have received one to two prior lines of therapy.
The following is a listing of clinical trials for patients with multiple myeloma who have received three or more prior lines of therapy.
The following is a listing of clinical trials for patients with Smoldering Myeloma.
The following is a listing of clinical trials for patients with Monoclonal Gammopathy of Undetermined Significance (MGUS).
There are no resources, links or videos to display for this center.
SparkCures is working closely with UCSF Helen Diller Comprehensive Cancer Center University of California San Francisco to provide the most up-to-date information on their myeloma program, specialists and clinical trials. Use the buttons above to claim this as your Home Center or add it to your List of Favorites.
Learn more about how we work with myeloma centers